• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Host Microbe . Antibody escape and cryptic cross-domain stabilization in the SARS-CoV-2 Omicron spike protein

tetano

Editor, Senior Moderator
Cell Host Microbe


. 2022 Aug 4;S1931-3128(22)00362-6.
doi: 10.1016/j.chom.2022.07.016. Online ahead of print.
Antibody escape and cryptic cross-domain stabilization in the SARS-CoV-2 Omicron spike protein


Kamyab Javanmardi[SUP] 1 [/SUP], Thomas H Segall-Shapiro[SUP] 2 [/SUP], Chia-Wei Chou[SUP] 3 [/SUP], Daniel R Boutz[SUP] 4 [/SUP], Randall J Olsen[SUP] 5 [/SUP], Xuping Xie[SUP] 6 [/SUP], Hongjie Xia[SUP] 6 [/SUP], Pei-Yong Shi[SUP] 6 [/SUP], Charlie D Johnson[SUP] 7 [/SUP], Ankur Annapareddy[SUP] 3 [/SUP], Scott Weaver[SUP] 8 [/SUP], James M Musser[SUP] 9 [/SUP], Andrew D Ellington[SUP] 10 [/SUP], Ilya J Finkelstein[SUP] 11 [/SUP], Jimmy D Gollihar[SUP] 12 [/SUP]



Affiliations

Abstract

The worldwide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to the repeated emergence of variants of concern. For the Omicron variant, sub-lineages BA.1 and BA.2, respectively, contain 33 and 29 nonsynonymous and indel spike protein mutations. These amino acid substitutions and indels are implicated in increased transmissibility and enhanced immune evasion. By reverting individual spike mutations of BA.1 or BA.2, we characterize the molecular effects of the Omicron spike mutations on expression, ACE2 receptor affinity, and neutralizing antibody recognition. We identified key mutations enabling escape from neutralizing antibodies at a variety of epitopes. Stabilizing mutations in the N-terminal and S2 domains of the spike protein can compensate for destabilizing mutations in the receptor binding domain, enabling the record number of mutations in Omicron. Our results provide a comprehensive account of the mutational effects in the Omicron spike protein and illustrate previously uncharacterized mechanisms of host evasion.

Keywords: COVID-19; VOCs; cell display; flow cytometry; high throughput; viral glycoprotein.
 
Back
Top Bottom